Vote Scores
Filings read through

ASKA Pharmaceutical Holdings Co., Ltd.: how funds voted at the meeting of 24 Jun 2025

Meeting
Season
year to 30 June 2025
Filers reporting
20
Ballot items
11

20 filers on Form N-PX reported votes at the ASKA Pharmaceutical Holdings Co., Ltd. meeting of 24 Jun 2025. The records fall into 11 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of ASKA Pharmaceutical Holdings Co., Ltd. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    9 nominees. 100.0% of the reported votes are for. No filer withheld from or voted against a nominee.

    234 vote records from 19 filers. 0 of the 19 filers that marked the item voted against management.

    • Positions of 12 fund families
    • For 12
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    1 vote record from 1 filer. 1 of the 1 filer that marked the item voted against management.

  3. Item 3: Audit-related items (auditor ratification)

    12 vote records from 3 filers. 0 of the 3 filers that marked the item voted against management.

    • Positions of one fund family
    • For 1
  4. Item 4: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    26 vote records from 19 filers. 0 of the 19 filers that marked the item voted against management.

    • Positions of 12 fund families
    • For 12
  5. Item 5: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    76 vote records from 13 filers. 0 of the 13 filers that marked the item voted against management.

    • Positions of 9 fund families
    • For 8
    • Split or no vote 1
  6. Item 6: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    18 vote records from 3 filers. 0 of the 3 filers that marked the item voted against management.

    • Positions of 2 fund families
    • For 2
  7. Item 7: OTHER: management items

    The company's items in this category are shown together, because filers word and number them differently.

    3 vote records from 3 filers. No filer marked the item for or against management. 3 filers gave no management mark.

    • Positions of one fund family
    • Split or no vote 1
  8. Item 8: Amend Articles to Require Majority Outsider Board

    26 vote records from 19 filers. 0 of the 19 filers that marked the item voted against management.

    • Positions of 12 fund families
    • Against 12
  9. Item 9: Approve Restricted Stock Plan

    26 vote records from 19 filers. 9 of the 19 filers that marked the item voted against management.

    • Positions of 12 fund families
    • For 5
    • Against 7
    • Against management 5
  10. Item 10: Initiate Share Repurchase Program

    21 vote records from 15 filers. 0 of the 15 filers that marked the item voted against management.

    • Positions of 10 fund families
    • Against 10
  11. Item 11: Shareholder Proposal: Approve Purchase of Own Shares

    5 vote records from 4 filers. 0 of the 4 filers that marked the item voted against management.

    • Positions of 2 fund families
    • Against 2

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at ASKA Pharmaceutical Holdings Co., Ltd., meeting of 24 Jun 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family3. Auditor8. Proposal9. Proposal10. Proposal11. Proposal
American CenturyNo reportAgainstAgainstAgainstNo report
BlackRock and iSharesNo reportAgainstAgainstNo reportAgainst
Brighthouse FundsNo reportAgainstFor, against managementAgainstNo report
Charles SchwabNo reportAgainstAgainstAgainstNo report
DimensionalNo reportAgainstFor, against managementAgainstNo report
EquitableNo reportAgainstAgainstAgainstNo report
John Hancock and ManulifeForAgainstFor, against managementNo reportAgainst
Lincoln FinancialNo reportAgainstFor, against managementAgainstNo report
State Street and SPDRNo reportAgainstAgainstAgainstNo report
VanguardNo reportAgainstAgainstAgainstNo report
VoyaNo reportAgainstAgainstAgainstNo report
WisdomTreeNo reportAgainstFor, against managementAgainstNo report

Questions

How many filers reported votes at the ASKA Pharmaceutical Holdings Co., Ltd. meeting?
20 Form N-PX filers reported votes at the meeting of 24 Jun 2025. On say-on-pay, 1 of 1 filers that marked the item voted against management (100.0%). The filings show 4 separate proposals from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. ASKA Pharmaceutical Holdings Co., Ltd. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list ASKA Pharmaceutical Holdings Co., Ltd. with a meeting date within three days of 24 Jun 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .